Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Examining concerns regarding FDA's proposed changes to generic drug labeling : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014
| Examining concerns regarding FDA's proposed changes to generic drug labeling : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014 |
| Pubbl/distr/stampa | Washington : , : U.S. Government Publishing Office, , 2016 |
| Descrizione fisica | 1 online resource (v, 146 pages) |
| Soggetto topico |
Generic drugs - Labeling - United States
Drugs - Safety regulations - United States Warning labels - Government policy - United States |
| Soggetto genere / forma | Legislative hearings. |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Examining concerns regarding FDA's proposed changes to generic drug labeling |
| Record Nr. | UNINA-9910707021503321 |
| Washington : , : U.S. Government Publishing Office, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Making Objective Drug Evidence Revisions for New Labeling Act of 2020 : report (to accompany H.R. 5668) (including cost estimate of the Congressional Budget Office)
| Making Objective Drug Evidence Revisions for New Labeling Act of 2020 : report (to accompany H.R. 5668) (including cost estimate of the Congressional Budget Office) |
| Pubbl/distr/stampa | [Washington, D.C.] : , : [U.S. Government Publishing Office], , [2020] |
| Descrizione fisica | 1 online resource (14 pages) |
| Collana | Report / 116th Congress, 2d session, House of Representatives |
| Soggetto topico |
Generic drugs - Law and legislation - United States
Generic drugs - Labeling - United States Generic drugs - Safety regulations - United States Warning labels - Government policy - United States |
| Soggetto genere / forma | Legislative materials. |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Making Objective Drug Evidence Revisions for New Labeling Act of 2020 |
| Record Nr. | UNINA-9910715015003321 |
| [Washington, D.C.] : , : [U.S. Government Publishing Office], , [2020] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
